Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Benjamin L Lampson

7PUBLICATIONS

43CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Biologically active moleculesCarbon capture engineering (excl. sequestration)Respiratory diseases

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Dec 07, 2024

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Matthew S Davids, Christine E Ryan, Benjamin L Lampson

|Oct 31, 2022

Rare Germline <i>ATM</i> Variants Influence the Development of Chronic Lymphocytic Leukemia.

Benjamin L Lampson, Aditi Gupta, Svitlana Tyekucheva

|Feb 06, 2021

Targeting oncoproteins with a positive selection assay for protein degraders.

Vidyasagar Koduri, Leslie Duplaquet, Benjamin L Lampson

|Apr 11, 2019

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia.

Benjamin L Lampson, Haesook T Kim, Matthew S Davids

|Oct 13, 2018

A new triple threat to CLL.

Benjamin L Lampson, Matthew S Davids

|Feb 23, 2017

Ventricular arrhythmias and sudden death in patients taking ibrutinib.

Benjamin L Lampson, Lijian Yu, Robert J Glynn

Pageof 2

Frequent Collaborators

3 joint publications

Jennifer R Brown

2 joint publications

Joshua Fein

2 joint publications

Svitlana Tyekucheva

1 joint publications

Elizabeth A Morgan

1 joint publications

Jerome Ritz

1 joint publications

Haesook T Kim

1 joint publications

Jacqueline C Barrientos

1 joint publications

Versha Banerji

1 joint publications

Kerry J Savage

1 joint publications

Jeremy S Abramson

Frequent Collaborators

3 joint publications

Jennifer R Brown

2 joint publications

Joshua Fein

2 joint publications

Svitlana Tyekucheva

1 joint publications

Elizabeth A Morgan

Top Related Videos

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on : Dec 04, 2018

Derivation of Thymic Lymphoma T-cell Lines from <em>Atm<sup>-/-</sup></em> and <em>p53<sup>-/-</sup></em> Mice

Derivation of Thymic Lymphoma T-cell Lines from <em>Atm<sup>-/-</sup></em> and <em>p53<sup>-/-</sup></em> Mice

Published on : Apr 03, 2011

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on : Nov 09, 2020

See more related videos

Top Related Videos

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on : Dec 04, 2018

Derivation of Thymic Lymphoma T-cell Lines from <em>Atm<sup>-/-</sup></em> and <em>p53<sup>-/-</sup></em> Mice

Derivation of Thymic Lymphoma T-cell Lines from <em>Atm<sup>-/-</sup></em> and <em>p53<sup>-/-</sup></em> Mice

Published on : Apr 03, 2011

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on : Nov 09, 2020

See more related videos